Company
United StatesMarshallton Capital Group, Newark, DE – FDA Inspections
Inspection records and compliance data for Marshallton Capital Group in Newark, Delaware. 3 FDA inspections on record, last inspected March 15, 2019.
Company Profile
This profile covers Marshallton Capital Group based in Newark, Delaware, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected July 5, 2011. Last inspected March 15, 2019.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 15, 2019 | NAI | Biologics · Blood and Blood Products | 1086716 |
| November 23, 2015 | NAI | Biologics · Blood and Blood Products | 951773 |
| July 5, 2011 | NAI | Biologics · Blood and Blood Products | 736657 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
B Positive National Blood Services
Shady Grove Fertility Center of Pennsylvania, PLLC
CSL Plasma Inc.
Wilmington Veterans Affairs Medical Center
Blood Bank Of Delmarva, Inc.
Fulda, Gerard J., M.D.
Christiana Care Health Services/Wilmington Hospital
Reproductive Associates Of Delaware
Blood Bank of Delmarva a Division of New York Blood Center
Christiana Care Health Services
Company Information
Name
Marshallton Capital Group
FEI Number
3003850688
Address
1711 Valley Stream Dr, Newark, Delaware 19702, United States
Country
United States
ID: c014aa6a-4996-4cee-85d6-418d82476179